Patents by Inventor Scott A. Meyer

Scott A. Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7941219
    Abstract: A methods and devices for capture detection are based on sensing a propagated depolarization from a contralateral cardiac chamber. An intersite sensing interval is determined based on an intersite pacing delay and an intersite conduction delay associated with first and second pacing sites. Pacing pulses are delivered to the first pacing site and the second pacing site, the pacing pulses separated in time by the intersite pacing delay. An intersite sensing interval is timed. The process includes sensing, during the intersite sensing interval, at the first pacing site for a depolarization propagated to the first pacing site from the second pacing site. It a depolarization propagated from the second pacing site is not sensed, then capture of the first and second pacing sites is detected.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: May 10, 2011
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Alok S. Sathaye, M. Jason Brooke, Scott A. Meyer
  • Publication number: 20110093500
    Abstract: A new database design is implemented in which everything in the database is modeled with primitives, including the links and nodes for a graph tuple store. A query syntax provides a nested tree of constraints with a single global schema. Various optimization techniques for queries and replication techniques are also 10 described.
    Type: Application
    Filed: December 23, 2010
    Publication date: April 21, 2011
    Applicant: GOOGLE INC.
    Inventors: Scott Meyer, Jutta Degener, Barak Michener, John Giannandrea
  • Patent number: 7917196
    Abstract: Cardiac monitoring and/or stimulation methods and systems provide for monitoring, diagnosing, defibrillation and pacing therapies, or a combination of these capabilities, including cardiac systems incorporating or cooperating with neuro-stimulating devices, drug pumps, or other therapies. Embodiments relate generally to implantable medical devices employing automated cardiac activation sequence monitoring and/or tracking for arrhythmia discrimination. Embodiments are directed to devices and methods involving sensing a plurality of composite cardiac signals using a plurality of implantable electrodes. A source separation is performed using the sensed plurality of composite cardiac signals and the separation produces one or more cardiac signal vectors associated with one or more cardiac activation sequences that is indicative of ischemia. A change of the one or more cardiac signal vectors is detected using the one or more cardiac signal vectors.
    Type: Grant
    Filed: May 9, 2005
    Date of Patent: March 29, 2011
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Yi Zhang, Carlos Alberto Ricci, Jeffrey E. Stahmann, Aaron R. McCabe, Scott A. Meyer, Yinghong Yu
  • Patent number: 7917215
    Abstract: Cardiac monitoring and/or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and/or trend closed-loop cardiac resynchronization therapy using cardiac activation sequence information. Devices and methods involve sensing a plurality of composite cardiac signals using a plurality of electrodes, the electrodes configured for implantation in a patient. A source separation is performed using the sensed plurality of composite cardiac signals, producing one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences. A cardiac resynchronization therapy is adjusted using one or both of the one or more cardiac signal vectors and the signals associated with the one or more cardiac signal vectors.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: March 29, 2011
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Yi Zhang, Yinghong Yu, Aaron McCabe, Jiang Ding, Jeffrey E. Stahmann, Carlos A. Ricci, Scott A. Meyer
  • Publication number: 20110063573
    Abstract: One embodiment of the present invention accounts for individual anatomical variation when evaluating optical nerve fiber measurements. In one aspect, contextual information is used to compensate or correct measurement data. In another aspect, reference coordinates are remapped for improved comparison or visualization. In one embodiment of this latter aspect, the method uses measurements of nerve fiber capacity and maps of nerve fiber retinal service to improve sensitivity and specificity in eye function metrics. In one instance, we use the birefringence of nerve fibers to determine the orientation of the fibers within the RNFL. Orientation of the fibers about the ONH is indicative of the service provided by the fibers and is used to improve the interpretation of thickness measurements of the nerve fiber layer. Normalized nerve fiber measurements about the optic nerve head improve specificity and sensitivity as compared to the standard model.
    Type: Application
    Filed: August 19, 2010
    Publication date: March 17, 2011
    Applicant: Carl Zeiss Meditec, Inc.
    Inventors: Scott A. MEYER, Mary K. Durbin, Paul F. Stetson, Bagrat Amirbekian
  • Publication number: 20110043757
    Abstract: A line scan imager is used to determine the motion of a subject. Each line of image data from the line scan imager is compared with a reference image. The location of a matching line in the reference image reveals the displacement of the subject. The current subject displacement can be determined based on each line of image data. The resulting displacement information can be used to correctly place other optical beams on the subject. The method can be applied to tracking the human eye to facilitate measurement, imaging, or treatment with a beam of optical radiation.
    Type: Application
    Filed: August 23, 2010
    Publication date: February 24, 2011
    Applicant: Carl Zeiss Meditec, Inc.
    Inventors: Matthew J. Everett, Claus Flachenecker, Martin Hacker, Scott A. Meyer, Keith E. O'Hara, RicK A. Williams
  • Patent number: 7890159
    Abstract: Cardiac monitoring and/or stimulation methods and systems provide monitoring, diagnosis, and defibrillation and/or pacing therapies. A signal processor receives a plurality of composite signals associated with a plurality of sources, performs a source separation, and produces one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences based on the source separation. A method of signal separation involves detecting a change in a characteristic of the cardiac signal vector relative to a baseline. One or more vectors and/or activation sequences may be selected, and information associated with the vectors and/or activation sequences may be stored and tracked.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: February 15, 2011
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Yi Zhang, Scott A. Meyer, Aaron McCabe, Jeffrey E. Stahmann, Yinghong Yu, Carlos Alberto Ricci
  • Patent number: 7878651
    Abstract: An optical coherence tomography apparatus and method for measuring refractive power of the human cornea is disclosed. The apparatus collects both the specularly reflected light from the anterior surface of the cornea and diffusely reflected light from the interior of the cornea. The combined refractive power of both surfaces of the cornea is determined.
    Type: Grant
    Filed: December 16, 2008
    Date of Patent: February 1, 2011
    Assignee: Carl Zeiss Meditec, Inc.
    Inventors: Keith E. O'Hara, Scott A. Meyer
  • Publication number: 20100305649
    Abstract: A system and method for detecting and treating symptoms of early decompensation utilizing a cardiac rhythm management. The system applies an electrical stimulus to the patient's heart at a first set of pacing parameters including a lower rate limit (LRL) setting, and acquires a coronary venous pressure (CVP) signal from a pressure sensor implanted in a coronary vein of the patient. An average coronary venous end diastolic pressure (CV-EDP) value is calculated from the CVP signal. The system monitors the average CV-EDP value over a predetermined interval, and dynamically adjusts the LRL setting responsive to the detection of a first or a second predetermined event based on the average CV-EDP value.
    Type: Application
    Filed: May 26, 2010
    Publication date: December 2, 2010
    Inventors: Barun Maskara, Lili Liu, Guy Alvarez, Scott A. Meyer
  • Publication number: 20100305650
    Abstract: A system and method for pacing rate control in a cardiac rhythm management (CRM) system. The method includes acquiring a pressure signal representative of coronary venous pressure (CVP) from a pressure sensor implanted within a coronary vein of the patient and generating a CVP waveform from the pressure signal. A pacing stimulus is applied to the patient's heart, and the pacing rate is increased in response to increases in patient's metabolic demand. The CVP index is monitored during the pacing rate increase, and the CRM system detects a reduction in the patient's hemodynamic performance based on the CVP index and establishes a maximum rate setting based on the pacing rate corresponding to the reduction in the patient's hemodynamic performance.
    Type: Application
    Filed: May 26, 2010
    Publication date: December 2, 2010
    Inventors: Barun Maskara, Lili Liu, Guy Alvarez, Scott A. Meyer
  • Publication number: 20100304355
    Abstract: Devices, in vitro cell cultures, systems, and methods are provided for microscale cell culture analogous (CCA) device.
    Type: Application
    Filed: September 8, 2006
    Publication date: December 2, 2010
    Inventors: Michael Shuler, Gregory T. Baxter, Aaron Sin, Robert Andrew Harrison, Scott Meyers
  • Publication number: 20100298729
    Abstract: Cardiac monitoring and/or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and/or trend ischemia using cardiac activation sequence information. Ischemia detection may involve sensing composite cardiac signals using implantable electrodes, and performing a signal separation that produces one or more cardiac activation signal vectors associated with one or more cardiac activation sequences. A change in the signal vector may be detected using subsequent separations. The change may be an elevation or depression of the ST segment of a cardiac cycle or other change indicative of myocardial ischemia, myocardial infarction, or other pathological change. The change may be used to predict, quantify, and/or qualify an event such as an arrhythmia, a myocardial infarction, or other pathologic change. Information associated with the vectors may be stored and used to track the vectors.
    Type: Application
    Filed: July 30, 2010
    Publication date: November 25, 2010
    Inventors: Yi Zhang, Scott A. Meyer, Jeffrey E. Stahmann, Carlos Alberto Ricci, Marina Brockway, Aaron R. McCabe, Yinghong Yu, Donald L. Hopper
  • Publication number: 20100278402
    Abstract: Various methods are disclosed for mapping optical coherence tomography (OCT) data to facilitate review and diagnosis. In one aspect, high resolution 2D line scans are obtained along with lower density 3D cube scans and displayed in a manner to provide context to the clinician. In another aspect, QCT data is analyzed to provide information about non-uniformities of the tissue. Binary image maps of maps useful for determining tautness of membranes are also disclosed.
    Type: Application
    Filed: June 23, 2010
    Publication date: November 4, 2010
    Applicant: Carl Zeiss Meditec, Inc.
    Inventors: Matthew J. EVERETT, Paul F. STETSON, Scott A. MEYER, Shahram Shawn DASTMALCHI
  • Publication number: 20100258513
    Abstract: Some embodiments of a product display system can be employed in a retail store or other product storage environment to maintain one or more rows of products in an organized manner on a shelf. In some circumstances, the display system can be readily assembled to the shelf and thereafter receive products so that the products can remain visible and advanced toward the front portion of the shelf.
    Type: Application
    Filed: April 8, 2009
    Publication date: October 14, 2010
    Applicant: TARGET BRANDS, INC.
    Inventors: Scott Meyer, Andy Vartanian
  • Publication number: 20100262207
    Abstract: Methods and systems for detecting noise in cardiac pacing response classification processes involve determining that a cardiac response classification is possibly erroneous if unexpected signal content is detected. The unexpected signal content may comprise signal peaks that have polarity opposite to the polarity of peaks used to determine the cardiac response to pacing. Fusion/noise management processes include pacing at a relatively high energy level until capture is detected after a fusion, indeterminate, or possibly erroneous pacing response classification is made. The relatively high energy pacing pulses may be delivered until capture is detected or until a predetermined number of paces are delivered.
    Type: Application
    Filed: June 24, 2010
    Publication date: October 14, 2010
    Inventors: Kevin John Stalsberg, Yanting Dong, Scott A. Meyer, John Michael Voegele, Derek Daniel Bohn, Eric Keith Enrooth, Clayton Scott Foster, David William Yost
  • Publication number: 20100256703
    Abstract: Methods and devices for classifying a cardiac response to pacing involve establishing a retriggerable cardiac response classification window. A first cardiac response classification window is established subsequent to delivery of a pacing pulse. A cardiac signal following the pacing stimulation is sensed in the first classification window. A second cardiac response classification may be triggered if a trigger characteristic is detected in the first classification window. The cardiac signal is sensed in the second classification window if the second classification window is established. The cardiac response to the pacing stimulation is determined based on characteristics of the cardiac signal. The cardiac response may be determined to be one of a captured response, a non-captured response, a non-captured response added to an intrinsic beat, and a fusion/pseudofusion beat, for example.
    Type: Application
    Filed: June 17, 2010
    Publication date: October 7, 2010
    Inventors: Scott A. Meyer, Yanting Dong, Jeremy Maniak, Doug Birholz, John Voegele
  • Patent number: 7805009
    Abstract: A line scan imager is used to determine the motion of a subject. Each line of image data from the line scan imager is compared with a reference image. The location of a matching line in the reference image reveals the displacement of the subject. The current subject displacement can be determined based on each line of image data. The resulting displacement information can be used to correctly place other optical beams on the subject. The method can be applied to tracking the human eye to facilitate measurement, imaging, or treatment with a beam of optical radiation.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: September 28, 2010
    Assignee: Carl Zeiss Meditec, Inc.
    Inventors: Matthew J. Everett, Claus Flachenecker, Martin Hacker, Scott A. Meyer, Keith E. O'Hara, Rick A. Williams
  • Patent number: 7798647
    Abstract: One embodiment of the present invention accounts for individual anatomical variation when evaluating optical nerve fiber measurements. In one aspect, contextual information is used to compensate or correct measurement data. In another aspect, reference coordinates are remapped for improved comparison or visualization. In one embodiment of this latter aspect, the method uses measurements of nerve fiber capacity and maps of nerve fiber retinal service to improve sensitivity and specificity in eye function metrics. In one instance, we use the birefringence of nerve fibers to determine the orientation of the fibers within the RNFL. Orientation of the fibers about the ONH is indicative of the service provided by the fibers and is used to improve the interpretation of thickness measurements of the nerve fiber layer. Normalized nerve fiber measurements about the optic nerve head improve specificity and sensitivity as compared to the standard model.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: September 21, 2010
    Assignee: Carl Zeiss Meditec, Inc.
    Inventors: Scott A. Meyer, Mary K. Durbin, Paul F. Stetson, Bagrat Amirbekian
  • Patent number: 7797036
    Abstract: Cardiac monitoring and/or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and/or trend ischemia using cardiac activation sequence information. Ischemia detection may involve sensing composite cardiac signals using implantable electrodes, and performing a signal separation that produces one or more cardiac activation signal vectors associated with one or more cardiac activation sequences. A change in the signal vector may be detected using subsequent separations. The change may be an elevation or depression of the ST segment of a cardiac cycle or other change indicative of myocardial ischemia, myocardial infarction, or other pathological change. The change may be used to predict, quantify, and/or qualify an event such as an arrhythmia, a myocardial infarction, or other pathologic change. Information associated with the vectors may be stored and used to track the vectors.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: September 14, 2010
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Yi Zhang, Scott A. Meyer, Jeffrey E. Stahmann, Carlos Alberto Ricci, Marina Brockway, Aaron R. McCabe, Yinghong Yu, Donald I. Hopper
  • Patent number: D624341
    Type: Grant
    Filed: December 3, 2009
    Date of Patent: September 28, 2010
    Assignee: Target Brands, Inc.
    Inventors: Phillip L. Noren, Scott A. Meyer, Michael M. Habig, Sam J. Clavette, Stacy L. Abel